1. Martin SA, Haren MT, Marshall VR, Lange K, Wittert GA. Prevalence and factors associated with uncomplicated storage and voiding lower urinary tract symptoms in community-dwelling Australian men. World J Urol. 2011; 29:179–184. PMID:
20963421.
Article
2. Chapple CR. Lower urinary tract symptoms suggestive of benign prostatic obstruction--triumph: design and implementation. Eur Urol. 2001; 39(Suppl 3):31–36. PMID:
11275740.
3. Oelke M, Bachmann A, Descazeaud A, Emberton M, Gravas S, Michel MC, et al. EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol. 2013; 64:118–140. PMID:
23541338.
Article
4. Malek RS, Kuntzman RS, Barrett DM. Photoselective potassium-titanyl-phosphate laser vaporization of the benign obstructive prostate: observations on long-term outcomes. J Urol. 2005; 174:1344–1348. PMID:
16145416.
Article
5. Lee R, Gonzalez RR, Te AE. The evolution of photoselective vaporization prostatectomy (PVP): advancing the surgical treatment of benign prostatic hyperplasia. World J Urol. 2006; 24:405–409. PMID:
16699795.
Article
6. Bachmann A, Ruszat R, Wyler S, Reich O, Seifert HH, Müller A, et al. Photoselective vaporization of the prostate: the basel experience after 108 procedures. Eur Urol. 2005; 47:798–804. PMID:
15925076.
Article
7. Bouchier-Hayes DM, Van Appledorn S, Bugeja P, Crowe H, Challacombe B, Costello AJ. A randomized trial of photoselective vaporization of the prostate using the 80-W potassium-titanyl-phosphate laser vs transurethral prostatectomy, with a 1-year follow-up. BJU Int. 2010; 105:964–969. PMID:
19912196.
Article
8. Horasanli K, Silay MS, Altay B, Tanriverdi O, Sarica K, Miroglu C. Photoselective potassium titanyl phosphate (KTP) laser vaporization versus transurethral resection of the prostate for prostates larger than 70 mL: a short-term prospective randomized trial. Urology. 2008; 71:247–251. PMID:
18308094.
Article
9. Al-Ansari A, Younes N, Sampige VP, Al-Rumaihi K, Ghafouri A, Gul T, et al. GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for treatment of benign prostatic hyperplasia: a randomized clinical trial with midterm follow-up. Eur Urol. 2010; 58:349–355. PMID:
20605316.
Article
10. Capitán C, Blázquez C, Martin MD, Hernández V, de la Peña E, Llorente C. GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia: a randomized clinical trial with 2-year follow-up. Eur Urol. 2011; 60:734–739. PMID:
21658839.
Article
11. Lukacs B, Loeffler J, Bruyère F, Blanchet P, Gelet A, Coloby P, et al. Photoselective vaporization of the prostate with GreenLight 120-W laser compared with monopolar transurethral resection of the prostate: a multicenter randomized controlled trial. Eur Urol. 2012; 61:1165–1173. PMID:
22341632.
Article
12. Mohanty NK, Vasudeva P, Kumar A, Prakash S, Jain M, Arora RP. Photoselective vaporization of prostate vs. transurethral resection of prostate: a prospective, randomized study with one year follow-up. Indian J Urol. 2012; 28:307–312. PMID:
23204660.
Article
13. Pereira-Correia JA, de Moraes Sousa KD, Santos JB, de Morais Perpétuo D, Lopes-da-Silva LF, Krambeck RL, et al. GreenLight HPS™ 120-W laser vaporization vs transurethral resection of the prostate (<60 mL): a 2-year randomized double-blind prospective urodynamic investigation. BJU Int. 2012; 110:1184–1189. PMID:
22257240.
14. Kumar A, Vasudeva P, Kumar N, Nanda B, Jha SK, Mohanty N. A prospective randomized comparative study of monopolar and bipolar transurethral resection of the prostate and photoselective vaporization of the prostate in patients who present with benign prostatic obstruction: a single center experience. J Endourol. 2013; 27:1245–1253. PMID:
23746047.
Article
15. Xue B, Zang Y, Zhang Y, Yang D, Gao J, Sun C, et al. GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for treatment of benign prostatic hyperplasia: a prospective randomized trial. J Xray Sci Technol. 2013; 21:125–132. PMID:
23507858.
Article
16. Telli O, Okutucu TM, Suer E, Burgu B, Gulpinar O, Yaman O, et al. A prospective, randomized comparative study of monopolar transurethral resection of the prostate versus photoselective vaporization of the prostate with GreenLight 120-W laser, in prostates less than 80 cc. Ther Adv Urol. 2015; 7:3–8. PMID:
25642290.
17. Cetinkaya M, Onem K, Rifaioglu MM, Yalcin V. 980-Nm diode laser vaporization versus transurethral resection of the prostate for benign prostatic hyperplasia: randomized controlled study. Urol J. 2015; 12:2355–2361. PMID:
26571321.
18. Chung JH, Lee SW. Assessing the quality of randomized controlled urological trials conducted by Korean medical institutions. Korean J Urol. 2013; 54:289–296. PMID:
23700493.
Article
19. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994; 50:1088–1101. PMID:
7786990.
Article
20. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997; 315:629–634. PMID:
9310563.
Article
21. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003; 327:557–560. PMID:
12958120.
Article
22. Fleiss JL. Analysis of data from multiclinic trials. Control Clin Trials. 1986; 7:267–275. PMID:
3802849.
Article
23. Galbraith RF. A note on graphical presentation of estimated odds ratios from several clinical trials. Stat Med. 1988; 7:889–894. PMID:
3413368.
Article
24. DerSimonian R, Kacker R. Random-effects model for meta-analysis of clinical trials: an update. Contemp Clin Trials. 2007; 28:105–114. PMID:
16807131.
Article
25. Teng J, Zhang D, Li Y, Yin L, Wang K, Cui X, et al. Photoselective vaporization with the green light laser vs transurethral resection of the prostate for treating benign prostate hyperplasia: a systematic review and meta-analysis. BJU Int. 2013; 111:312–323. PMID:
23145474.
Article
26. Ding H, Du W, Lu ZP, Zhai ZX, Wang HZ, Wang ZP. Photoselective green-light laser vaporisation vs. TURP for BPH: meta-analysis. Asian J Androl. 2012; 14:720–725. PMID:
22902908.
Article
27. Thangasamy IA, Chalasani V, Bachmann A, Woo HH. Photoselective vaporisation of the prostate using 80-W and 120-W laser versus transurethral resection of the prostate for benign prostatic hyperplasia: a systematic review with meta-analysis from 2002 to 2012. Eur Urol. 2012; 62:315–323. PMID:
22575913.
Article
28. Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia with age. J Urol. 1984; 132:474–479. PMID:
6206240.
Article
29. McVary KT, Roehrborn CG, Avins AL, Barry MJ, Bruskewitz RC, Donnell RF, et al. Update on AUA guideline on the management of benign prostatic hyperplasia. J Urol. 2011; 185:1793–1803. PMID:
21420124.
Article
30. Tan A, Liao C, Mo Z, Cao Y. Meta-analysis of holmium laser enucleation versus transurethral resection of the prostate for symptomatic prostatic obstruction. Br J Surg. 2007; 94:1201–1208. PMID:
17729384.
Article
31. Yin L, Teng J, Huang CJ, Zhang X, Xu D. Holmium laser enucleation of the prostate versus transurethral resection of the prostate: a systematic review and meta-analysis of randomized controlled trials. J Endourol. 2013; 27:604–611. PMID:
23167266.
Article
32. Li S, Zeng XT, Ruan XL, Weng H, Liu TZ, Wang X, et al. Holmium laser enucleation versus transurethral resection in patients with benign prostate hyperplasia: an updated systematic review with meta-analysis and trial sequential analysis. PLoS One. 2014; 9:e101615. PMID:
25003963.
Article
33. Wendt-Nordahl G, Huckele S, Honeck P, Alken P, Knoll T, Michel MS, et al. 980-nm diode laser: a novel laser technology for vaporization of the prostate. Eur Urol. 2007; 52:1723–1728. PMID:
17611013.
Article
34. Chen J, Wang M, Wang S, Sun P, Zhao Y, Zhang L, et al. 160-Watt lithium triboride laser vaporization versus transurethral resection of prostate: a prospective nonrandomized two-center trial. Urology. 2012; 79:650–654. PMID:
22386419.
Article
35. Ouyang Y, Liu C, Guan W, Zhao Y, Xu Y, Wu Y. Impact of 160 W Greenlight laser vaporization of the prostate on erectile function: a prospective randomized controlled trial with 1-year follow-up. Photomed Laser Surg. 2014; 32:463–467. PMID:
25101536.
Article
36. Castellan P, Castellucci R, Schips L, Cindolo L. Safety, efficacy and reliability of 180-W GreenLight laser technology for prostate vaporization: review of the literature. World J Urol. 2015; 33:599–607. PMID:
25647174.
Article
37. Reich O, Bachmann A, Schneede P, Zaak D, Sulser T, Hofstetter A. Experimental comparison of high power (80 W) potassium titanyl phosphate laser vaporization and transurethral resection of the prostate. J Urol. 2004; 171:2502–2504. PMID:
15126885.
Article
38. Choi YS, Bae WJ, Kim SJ, Kim KS, Cho HJ, Hong SH, et al. Efficacy and safety of 120-W GreenLight High-Performance System laser photo vaporization of the prostate: 3-year results with specific considerations. Prostate Int. 2013; 1:169–176. PMID:
24392442.
Article
39. Sandhu JS, Ng CK, Gonzalez RR, Kaplan SA, Te AE. Photoselective laser vaporization prostatectomy in men receiving anticoagulants. J Endourol. 2005; 19:1196–1198. PMID:
16359214.
Article
40. Sutton AJ, Duval SJ, Tweedie RL, Abrams KR, Jones DR. Empirical assessment of effect of publication bias on meta-analyses. BMJ. 2000; 320:1574–1577. PMID:
10845965.
Article